title: Eltrombopag for thrombocytopenic patients with hepatitis C virus infection and cirrhosis.
authors.affiliation: Department of General Surgery and Department of Infectious Disease, the Second Affiliated Hospital, College of Medicine, Xi'an Jiaotong University, Xi'an, China.
authors.forename: Fanpu
authors.initials: F
authors.lastname: Ji
authors.affiliation: Department of Infectious Disease, the Second Affiliated Hospital, College of Medicine, Xi'an Jiaotong University, Xi'an, China.
authors.forename: Hong
authors.initials: H
authors.lastname: Deng
authors.affiliation: Department of General Surgery, the Second Affiliated Hospital, College of Medicine, Xi'an Jiaotong University, Xi'an, China.
authors.forename: Zongfang
authors.initials: Z
authors.lastname: Li
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D005260:Female; D006401:Hematologic Agents / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D011720:Pyrazoles / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000188:drug therapy*
chemical_list: D000998:Antiviral Agents; D001565:Benzoates; D006401:Hematologic Agents; D006834:Hydrazines; D011720:Pyrazoles